In summary, the mechanisms underlying treatment-induced adaptive cancer cell survival in residual tumors of ALK-rearranged lung cancer are predominantly dependent on STAT3 activity and subsequent transcriptional regulation of apoptosis. The gene discussed is STAT3; the disease is lung cancer.